Volgen
Eric Topol
Eric Topol
Professor and EVP, Scripps Research
Geverifieerd e-mailadres voor scripps.edu - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
81319*2016
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
CAPRIE Steering Committee
The Lancet 348 (9038), 1329-1339, 1996
68561996
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
Gusto Investigators
New England Journal of Medicine 329 (10), 673-682, 1993
46551993
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ...
New England Journal of Medicine 354 (16), 1706-1717, 2006
37862006
High-performance medicine: the convergence of human and artificial intelligence
EJ Topol
Nature medicine 25 (1), 44-56, 2019
36652019
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial
SR Steinhubl, PB Berger, JT Mann III, ETA Fry, A DeLago, C Wilmer, ...
Jama 288 (19), 2411-2420, 2002
36542002
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
Epic Investigators
New England Journal of Medicine 330 (14), 956-961, 1994
30291994
Risk of cardiovascular events associated with selective COX-2 inhibitors
D Mukherjee, SE Nissen, EJ Topol
Jama 286 (8), 954-959, 2001
25022001
Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review
DP Oran, EJ Topol
Annals of internal medicine 173 (5), 362-367, 2020
22622020
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
Epilog Investigators
New England Journal of Medicine 336 (24), 1689-1697, 1997
21711997
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
GUSTO Angiographic Investigators
New England Journal of Medicine 329 (22), 1615-1622, 1993
21451993
Prevalence of conventional risk factors in patients with coronary heart disease
UN Khot, MB Khot, CT Bajzer, SK Sapp, EM Ohman, SJ Brener, SG Ellis, ...
Jama 290 (7), 898-904, 2003
21412003
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial
SE Nissen, EM Tuzcu, P Libby, PD Thompson, M Ghali, D Garza, ...
Jama 292 (18), 2217-2225, 2004
19032004
Chitin chemistry
GAF Roberts, GAF Roberts
macmillan, 1992
18781992
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
PURSUIT Trial Investigators
New England Journal of Medicine 339 (7), 436-443, 1998
16861998
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy
AT Askari, S Unzek, ZB Popovic, CK Goldman, F Forudi, M Kiedrowski, ...
The Lancet 362 (9385), 697-703, 2003
16412003
Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel …
SG Ellis, MG Vandormael, MJ Cowley, G DiSciascio, U Deligonul, ...
Circulation 82 (4), 1193-1202, 1990
15951990
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
EJ Topol
The Lancet 352 (9122), 87-92, 1998
15841998
Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial
MJ Price, PB Berger, PS Teirstein, JF Tanguay, DJ Angiolillo, D Spriggs, ...
Jama 305 (11), 1097-1105, 2011
15792011
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
PA Gum, K Kottke-Marchant, PA Welsh, J White, EJ Topol
Journal of the American College of Cardiology 41 (6), 961-965, 2003
15622003
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20